Credit Suisse Analyst Initiates Coverage on Allergen plc Ordinary Shares (AGN) with Outperform Rating
Credit Suisse analyst, Vamil Divan, initiates coverage on Allergen plc Ordinary Shares (NYSE:AGN) with an Outperform rating and a price target of $327.00.
According to the analyst, the company has a “broad and underappreciated pipeline that will help boost their already strong base business and that is trading at a compelling valuation and being led by a best-in-class management team.”
The analyst further explains that a compelling valuation with a positive risk reward remains very attractive for investors.
Tamil Divan is ranked #210 of 4,081 analysts on TipRanks. He maintains a success rate of 70% and realizes an average return of 12.7%.